Cargando…

Acceptability of telemedicine for follow up after contraceptive implant initiation at an obstetrics and gynecologic training center

BACKGROUND: During the COVID-19 pandemic, telemedicine has become a popular adjunct to in-person visits, including for family planning services. This study determined the proportion of clients participated in telemedicine services and the association between sociodemographic factors and telemedicine...

Descripción completa

Detalles Bibliográficos
Autores principales: Vatrasresth, Jarika, Prapaisilp, Peerapong, Sukrong, Monchada, Sinthuchai, Natchanika, Karroon, Parichart, Maitreechit, Duangporn, Ittipuripat, Sirarat, Kuptarak, Arissara, Sathitloetsakun, Sarochinee, Santibenchakul, Somsook, Jaisamrarn, Unnop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391934/
https://www.ncbi.nlm.nih.gov/pubmed/37525129
http://dx.doi.org/10.1186/s12913-023-09816-7
_version_ 1785082833381883904
author Vatrasresth, Jarika
Prapaisilp, Peerapong
Sukrong, Monchada
Sinthuchai, Natchanika
Karroon, Parichart
Maitreechit, Duangporn
Ittipuripat, Sirarat
Kuptarak, Arissara
Sathitloetsakun, Sarochinee
Santibenchakul, Somsook
Jaisamrarn, Unnop
author_facet Vatrasresth, Jarika
Prapaisilp, Peerapong
Sukrong, Monchada
Sinthuchai, Natchanika
Karroon, Parichart
Maitreechit, Duangporn
Ittipuripat, Sirarat
Kuptarak, Arissara
Sathitloetsakun, Sarochinee
Santibenchakul, Somsook
Jaisamrarn, Unnop
author_sort Vatrasresth, Jarika
collection PubMed
description BACKGROUND: During the COVID-19 pandemic, telemedicine has become a popular adjunct to in-person visits, including for family planning services. This study determined the proportion of clients participated in telemedicine services and the association between sociodemographic factors and telemedicine participation during the COVID-19 pandemic. The adverse effects within the first seven days post-insertion were also reported. METHODS: This retrospective cohort study considered data from all women initiating contraceptive implantation between June 2020 and August 2021 at King Chulalongkorn Memorial Hospital. Clients were offered the following two options for follow-up visits: in-person or communication via an online LINE® Official Account (LINE® OA), a free chat application widely used among the Thais. Logistic regression analyses were used to assess the association between socio-demographic factors and telehealth usage. RESULTS: In total, 574 of 947 (60.6%) clients participated in telemedicine follow-up services during the period considered. A significant association between telemedicine usage and the following were observed: the peak of second wave COVID-19 outbreak in Thailand, using the period preceding the second wave as a reference [adjusted odds ratio (aOR) = 1.47 (95% confidence interval [CI]: 1.12–1.96)]; participants receiving governmental benefits for contraceptive implant payment (aOR: 3.23, 95% CI: 1.86–5.60), and timing of contraceptive implant(s) initiation, using interval insertion as a reference for which aORs of postpartum and immediate postpartum insertions were 0.62 (95% CI: 0.43–0.90) and 0.35 (95% CI: 0.24–0.52), respectively. Significant ecchymosis at the insertion site was observed in 13.1% of participants. CONCLUSION: This study emphasizes the significance of telemedicine during the COVID-19 epidemic, particularly in facilitating contraceptive implant initiation. Our data show a significant increase in the uptake and utilization of telemedicine during the pandemic’s peak. The data also shows that during the period of Thailand’s second COVID-19 epidemic, government benefits for contraceptive implant payment, and the timing of contraceptive implant initiation, are significantly associated with telemedicine use. This finding supports the continued use of telemedicine in healthcare, particularly for services like family planning, where remote follow-ups can provide safe, efficient, and timely care.
format Online
Article
Text
id pubmed-10391934
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103919342023-08-02 Acceptability of telemedicine for follow up after contraceptive implant initiation at an obstetrics and gynecologic training center Vatrasresth, Jarika Prapaisilp, Peerapong Sukrong, Monchada Sinthuchai, Natchanika Karroon, Parichart Maitreechit, Duangporn Ittipuripat, Sirarat Kuptarak, Arissara Sathitloetsakun, Sarochinee Santibenchakul, Somsook Jaisamrarn, Unnop BMC Health Serv Res Research BACKGROUND: During the COVID-19 pandemic, telemedicine has become a popular adjunct to in-person visits, including for family planning services. This study determined the proportion of clients participated in telemedicine services and the association between sociodemographic factors and telemedicine participation during the COVID-19 pandemic. The adverse effects within the first seven days post-insertion were also reported. METHODS: This retrospective cohort study considered data from all women initiating contraceptive implantation between June 2020 and August 2021 at King Chulalongkorn Memorial Hospital. Clients were offered the following two options for follow-up visits: in-person or communication via an online LINE® Official Account (LINE® OA), a free chat application widely used among the Thais. Logistic regression analyses were used to assess the association between socio-demographic factors and telehealth usage. RESULTS: In total, 574 of 947 (60.6%) clients participated in telemedicine follow-up services during the period considered. A significant association between telemedicine usage and the following were observed: the peak of second wave COVID-19 outbreak in Thailand, using the period preceding the second wave as a reference [adjusted odds ratio (aOR) = 1.47 (95% confidence interval [CI]: 1.12–1.96)]; participants receiving governmental benefits for contraceptive implant payment (aOR: 3.23, 95% CI: 1.86–5.60), and timing of contraceptive implant(s) initiation, using interval insertion as a reference for which aORs of postpartum and immediate postpartum insertions were 0.62 (95% CI: 0.43–0.90) and 0.35 (95% CI: 0.24–0.52), respectively. Significant ecchymosis at the insertion site was observed in 13.1% of participants. CONCLUSION: This study emphasizes the significance of telemedicine during the COVID-19 epidemic, particularly in facilitating contraceptive implant initiation. Our data show a significant increase in the uptake and utilization of telemedicine during the pandemic’s peak. The data also shows that during the period of Thailand’s second COVID-19 epidemic, government benefits for contraceptive implant payment, and the timing of contraceptive implant initiation, are significantly associated with telemedicine use. This finding supports the continued use of telemedicine in healthcare, particularly for services like family planning, where remote follow-ups can provide safe, efficient, and timely care. BioMed Central 2023-07-31 /pmc/articles/PMC10391934/ /pubmed/37525129 http://dx.doi.org/10.1186/s12913-023-09816-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Vatrasresth, Jarika
Prapaisilp, Peerapong
Sukrong, Monchada
Sinthuchai, Natchanika
Karroon, Parichart
Maitreechit, Duangporn
Ittipuripat, Sirarat
Kuptarak, Arissara
Sathitloetsakun, Sarochinee
Santibenchakul, Somsook
Jaisamrarn, Unnop
Acceptability of telemedicine for follow up after contraceptive implant initiation at an obstetrics and gynecologic training center
title Acceptability of telemedicine for follow up after contraceptive implant initiation at an obstetrics and gynecologic training center
title_full Acceptability of telemedicine for follow up after contraceptive implant initiation at an obstetrics and gynecologic training center
title_fullStr Acceptability of telemedicine for follow up after contraceptive implant initiation at an obstetrics and gynecologic training center
title_full_unstemmed Acceptability of telemedicine for follow up after contraceptive implant initiation at an obstetrics and gynecologic training center
title_short Acceptability of telemedicine for follow up after contraceptive implant initiation at an obstetrics and gynecologic training center
title_sort acceptability of telemedicine for follow up after contraceptive implant initiation at an obstetrics and gynecologic training center
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391934/
https://www.ncbi.nlm.nih.gov/pubmed/37525129
http://dx.doi.org/10.1186/s12913-023-09816-7
work_keys_str_mv AT vatrasresthjarika acceptabilityoftelemedicineforfollowupaftercontraceptiveimplantinitiationatanobstetricsandgynecologictrainingcenter
AT prapaisilppeerapong acceptabilityoftelemedicineforfollowupaftercontraceptiveimplantinitiationatanobstetricsandgynecologictrainingcenter
AT sukrongmonchada acceptabilityoftelemedicineforfollowupaftercontraceptiveimplantinitiationatanobstetricsandgynecologictrainingcenter
AT sinthuchainatchanika acceptabilityoftelemedicineforfollowupaftercontraceptiveimplantinitiationatanobstetricsandgynecologictrainingcenter
AT karroonparichart acceptabilityoftelemedicineforfollowupaftercontraceptiveimplantinitiationatanobstetricsandgynecologictrainingcenter
AT maitreechitduangporn acceptabilityoftelemedicineforfollowupaftercontraceptiveimplantinitiationatanobstetricsandgynecologictrainingcenter
AT ittipuripatsirarat acceptabilityoftelemedicineforfollowupaftercontraceptiveimplantinitiationatanobstetricsandgynecologictrainingcenter
AT kuptarakarissara acceptabilityoftelemedicineforfollowupaftercontraceptiveimplantinitiationatanobstetricsandgynecologictrainingcenter
AT sathitloetsakunsarochinee acceptabilityoftelemedicineforfollowupaftercontraceptiveimplantinitiationatanobstetricsandgynecologictrainingcenter
AT santibenchakulsomsook acceptabilityoftelemedicineforfollowupaftercontraceptiveimplantinitiationatanobstetricsandgynecologictrainingcenter
AT jaisamrarnunnop acceptabilityoftelemedicineforfollowupaftercontraceptiveimplantinitiationatanobstetricsandgynecologictrainingcenter